Rico Auto Industries to open covid care center in Dharuhera

Pallavi Madhiraju- April 26, 2021 0

Rico Auto Industries said that it is establishing a covid care center in Dharuhera, Haryana at its manufacturing plant. The Indian auto parts company will ... Read More

India clears Zydus Cadila’s Virafin for treatment of moderate Covid-19

pallavi123- April 24, 2021 0

Zydus Cadila has secured restricted emergency use approval for ‘Virafin’, Pegylated Interferon alpha-2b (PegIFN) from the Drug Controller General of India (DCGI) for the treatment ... Read More

Russia’s RDIF gets Indian approval for Sputnik V Covid-19 vaccine

pallavi123- April 13, 2021 0

The Russian Direct Investment Fund (RDIF) has announced that the Sputnik V Covid-19 vaccine has been approved for use in India by the Drug Controller ... Read More

Dr. Reddy’s secures EUA for Sputnik V vaccine in India for Covid-19 prevention

pallavi123- April 13, 2021 0

Dr. Reddy’s Laboratories has secured permission from the Drug Controller General of India (DCGI) for importing the Sputnik V vaccine into India under emergency use ... Read More

Sound Pharmaceuticals gets NIH grant for Covid-19 candidate SPI-1005

pallavi123- April 6, 2021 0

Sound Pharmaceuticals has secured a grant of $3.1 million for supporting the evaluation of its COVID-19 treatment candidate SPI-1005 in two phase 2 clinical trials ... Read More

Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective

pallavi123- April 3, 2021 0

Spanish pharma company Grifols said that the phase 3 ITAC clinical trial assessing hyperimmune globulins as a treatment for patients hospitalized with Covid-19 has failed ... Read More

Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19

pallavi123- March 30, 2021 0

Tiziana Life Sciences said that it plans to launch a phase 2 clinical trial to evaluate the nasal administration of Foralumab in moderate to severe ... Read More

Foresee Pharmaceuticals begins FP-025 phase 2/3 trial in Covid-19 associated ARDS

pallavi123- March 28, 2021 0

Foresee Pharmaceuticals has started patient dosing in a phase 2/3 trial of FP-025 in adults having severe to critical Covid-19 with associated acute respiratory distress ... Read More

Janssen Covid‑19 vaccine gets conditional marketing authorization in EU

pallavi123- March 27, 2021 0

The European Commission has granted a conditional marketing authorization (CMA) for the single dose Janssen Covid‑19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson ... Read More

FDA accepts Airway’s IND for AT-100 for bronchopulmonary dysplasia treatment in preterm infants

pallavi123- March 27, 2021 0

Bronchopulmonary dysplasia treatment : Airway Therapeutics said that the US Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for developing ... Read More